Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result.
genetic counseling
practice models
service delivery models
Journal
Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
05
08
2022
received:
17
09
2021
accepted:
10
08
2022
pubmed:
30
8
2022
medline:
10
2
2023
entrez:
29
8
2022
Statut:
ppublish
Résumé
Several models of genetic counseling have been proposed to tackle the increasing volume of individuals requiring access to BRCA testing. Few data are available on patient experience and retention of information with nurse-driven genetic counseling. We evaluated the experience and retention of information in women with an uninformative BRCA test result and who were not considered at high risk due to their personal/family history of cancer who underwent geneticist-supervised nurse-driven genetic counseling and who received their test result by phone. Women who received an uninformative BRCA test result between May 2017 and September 2019 were administered a questionnaire exploring experience with genetic counseling and retention of information provided. Of 366 eligible women, 299 (273 breast cancer patients and 26 women without breast cancer) completed the interview. Overall, 280 women (93.6%) positively valued their experience with genetic counseling and 287 (96.0%) considered it helpful with 57.5% of them feeling reassured for themselves and their family. Information on the clinical implications of the test result was correctly retained and women acted accordingly. Overall, 252 women (87.8%) accurately reported their test result as normal/negative. Only 67 (22.4%) recognized that despite a normal BRCA test result, a low probability of a hereditary syndrome remains. Most women showed a poor ability to estimate cancer risk in BRCA mutation carriers and in the general population. Geneticist-supervised nurse-driven genetic counseling process for women with uninformative BRCA test result is associated with a positive patient experience and an adequate retention of information concerning the management of their personal and familial cancer risk. The design and implementation of nurse-driven genetic counseling models may contribute to efficient and timely access to BRCA genetic testing.
Identifiants
pubmed: 36036895
doi: 10.1002/jgc4.1630
pmc: PMC10087002
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
140-152Informations de copyright
© 2022 The Authors. Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.
Références
Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):98-107
pubmed: 29575600
Eur J Hum Genet. 2019 Aug;27(8):1186-1196
pubmed: 30962500
Clin Genet. 2019 Feb;95(2):293-301
pubmed: 30417332
Genet Med. 2007 Aug;9(8):487-95
pubmed: 17700386
J Genet Couns. 2018 Feb;27(1):131-139
pubmed: 28780754
J Genet Couns. 2013 Dec;22(6):902-6
pubmed: 23334530
Fam Cancer. 2022 Jul;21(3):309-318
pubmed: 34669096
Eur J Hum Genet. 2019 Apr;27(4):511-524
pubmed: 30573802
Cancers (Basel). 2018 Nov 13;10(11):
pubmed: 30428547
Eur J Hum Genet. 2019 Feb;27(2):183-197
pubmed: 30291341
Crit Rev Oncol Hematol. 2019 Aug;140:67-72
pubmed: 31176273
Gynecol Oncol. 2017 Apr;145(1):130-136
pubmed: 28162234
Br J Nurs. 2020 May 28;29(10):S6-S13
pubmed: 32463748
JAMA. 2019 Jan 1;321(1):27
pubmed: 30521006
J Genet Couns. 2016 Dec;25(6):1309-1316
pubmed: 27228984
Eur J Hum Genet. 2016 Sep;24 Suppl 1:S19-26
pubmed: 27514840
J Genet Couns. 2023 Feb;32(1):140-152
pubmed: 36036895
Br J Nurs. 2016 Jun 23;25(12):690-4
pubmed: 27345073
J Genet Couns. 2004 Apr;13(2):83-114
pubmed: 15604628
Genet Med. 2020 Aug;22(8):1401-1406
pubmed: 32376981
Sci Rep. 2016 Jul 13;6:29506
pubmed: 27406733
J Genet Couns. 2004 Aug;13(4):293-304
pubmed: 19736695
Front Oncol. 2016 May 13;6:120
pubmed: 27242960
J Clin Oncol. 2015 Nov 1;33(31):3660-7
pubmed: 26324357
Ann Oncol. 2004 May;15(5):726-32
pubmed: 15111339
N Engl J Med. 2021 Jun 24;384(25):2394-2405
pubmed: 34081848